Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2004
07/15/2004CA2511349A1 New substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
07/15/2004CA2510298A1 Acyclic pyrazole compounds
07/15/2004CA2509565A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
07/15/2004CA2508947A1 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
07/15/2004CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
07/14/2004EP1437342A2 Fluorinating reactants and process for their preparation
07/14/2004EP1436297A1 Photoactivable nitrogen bases
07/14/2004EP1436296A2 Process for the direct preparation of pyrrolo 3,4-c]pyrroles
07/14/2004EP1436291A2 Indolizines as kinase protein inhibitors
07/14/2004EP1436267A1 Lactam derivatives as antagonists for human 11cby receptors
07/14/2004EP1435960A1 Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists
07/14/2004EP1435957A2 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes
07/14/2004EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications
07/14/2004EP1435785A1 Iminobenzoxazines, iminobenzothiazines and iminoquinazolines for controlling invertebrate pests
07/14/2004EP1235803B1 Urea compounds having muscarinic receptor antagonist activity
07/14/2004EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
07/14/2004EP0983248B1 Analogs of duocarmycin and cc-1065
07/14/2004EP0976754B1 Remedies/preventives for respiratory diseases
07/14/2004CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer
07/14/2004CN1512994A Water soluble porphyri nderivatives for photodynamic therapy, their use and manufacture
07/14/2004CN1512993A Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
07/14/2004CN1512883A Crf受体拮抗剂 Crf receptor antagonist
07/14/2004CN1512881A Photosensitive and method for production thereof
07/14/2004CN1157393C Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine and its prep.
07/13/2004US6762194 Quinolinone derivatives
07/13/2004US6762185 Pyrazino(1,2-a)pyrimidine derivatives; wnt-signaling pathway modulation
07/13/2004US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma
07/13/2004US6762175 Fatty acid derivatives
07/13/2004US6762152 Four to seven membered heterocycles substituted on benzene ring; reaction of a ketone with a substituted benzoic acid
07/13/2004CA2047699C Expanded porphyrins: large prophyrin-like tripyrroledimethine-derived macrocycles
07/08/2004WO2004056831A1 PYRAZOLO [3,4-d] PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF H.PYLORI INFECTION
07/08/2004WO2004056830A1 Pyrrolopyrimidine derivatives
07/08/2004WO2004056828A2 Novel compounds and uses thereof
07/08/2004WO2004056827A2 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
07/08/2004WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments
07/08/2004WO2004056324A2 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
07/08/2004WO2004029578A3 Energy transfer dyes, terminators and use thereof
07/08/2004WO2004009017A3 Modulators of the glucocorticoid receptor and method
07/08/2004WO2004007498A3 3-phenyl analogs of toxoflavine as kinase inhibitors
07/08/2004US20040132781 Pyrazole compounds useful as protein kinase inhibitors
07/08/2004US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders
07/08/2004US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia.
07/08/2004US20040132751 Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops
07/08/2004US20040132734 Azaindoles having serotonin receptor affinity
07/08/2004US20040132725 tyrphostin preparations enriched in certain geometric isomers; treating protein tyrosine kinase related disorders. especially with slow release formulations
07/08/2004US20040132115 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity
07/08/2004US20040131545 Anticholesterol agents
07/08/2004DE19906979B4 Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit Use of deoxypeganine for the treatment of nicotine dependence
07/08/2004DE19906978B4 Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit Pharmaceutical composition containing deoxypeganine for the treatment of drug addiction
07/08/2004DE10260618A1 Tumorhemmende annellierte Azepinonderivate Tumor-inhibiting fused Azepinonderivate
07/08/2004DE10230490B4 Verfahren zur kontinuierlichen Herstellung von Acetylendiharnstoff Process for the continuous production of acetylene diurea
07/08/2004CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions
07/07/2004EP1435545A1 Organic electrophotographic photo-receptor
07/07/2004EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
07/07/2004EP1434778A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
07/07/2004EP1087971B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS
07/07/2004EP0918519B1 Therapeutic treatment for vegf related occular diseases
07/07/2004CN1511157A Novel pyrrole derivatives as pharmaceutical agents
07/07/2004CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives
07/07/2004CN1156478C Substituted porphyrins
07/07/2004CN1156477C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
07/06/2004US6759548 Dialkyl-halogenophenyl-substituted ketoenols
07/06/2004US6759405 Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
07/06/2004US6759403 Metalloporphyrins and their uses as radiosensitizers for radiation therapy
07/06/2004CA2312206C Novel bicyclic derivatives of amino-pyrazinones, process for preparing them and pharmaceutical compositions containing them
07/01/2004WO2004055163A2 Substituted 1-benzoyl-3-cyano-pyrrolo[1,2-a]quinolines
07/01/2004WO2004055018A1 Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines
07/01/2004WO2004055002A1 Carbazole derivatives and their use as npy-5 antagonists
07/01/2004WO2004054514A2 C-6 modified indazolylpyrrolotriazines
07/01/2004WO2004054498A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
07/01/2004WO2004043912A3 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
07/01/2004WO2004039774A3 Mitotic kinesin inhibitors
07/01/2004WO2004018058A3 Compounds, compositions, and methods
07/01/2004WO2004017911A3 Protease inhibitors
07/01/2004WO2004014294A3 4,7-disubstituted indoles and methods of making
07/01/2004WO2004005323A3 Affinity small molecules for the epo receptor
07/01/2004WO2004000802A3 Scaffolded maleimide clusters for multivalent peptide assembly
07/01/2004WO2003077215A3 Fluorescent nitrogenous base and nucleosides incorporating same
07/01/2004WO2003053445A8 Use of desoxypeganine for treating clinical depression
07/01/2004US20040127708 antiviral activities; aids treatment
07/01/2004US20040127707 Novel phthalazinones
07/01/2004US20040127534 Cellular adhesion molecule and leukointegrin inhibitors; inflammatory diseases; more slowly metabolized
07/01/2004US20040127530 treating gram-negative microbial infections
07/01/2004US20040127515 For therapy of hypertension, chronic obstructive pulmonary disease, organ damage, pain, diabetic nephropathy, dementia
07/01/2004US20040127509 5-Halogen-6-phenyl-7-fluoroalkylamino-triazolopyrimidines as fungicides
07/01/2004US20040127508 Substituted pyrazolopyrimidines and thiazolopyrimidines
07/01/2004US20040127492 Cyclic pyrazoles for the inhibition of mitogen activated protein kinase-activated protein kinase-2
07/01/2004US20040127491 For therapy of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases
07/01/2004US20040127483 Pyrazolopyrimidines as CRF receptor antagonists
07/01/2004US20040127482 Substituted heterocycle fused gamma-carbolines
07/01/2004US20040127481 Administering a therapeutic amount of a lidocaine, verapamil, diltiazem, isometheptene, or lisuride condensation aerosol
07/01/2004US20040126695 Fluoronorbornene, 7-azabicyclo[2.2.1]hept-5-ene and/or 7-oxobicyclo[2.2.1]hept-5-ene derivative monomers; photoresists, lithography
07/01/2004US20040126329 Delivery of analgesics through an inhalation route
07/01/2004US20040126328 Arerosol; heating drug, vaporization, cooling
07/01/2004US20040126327 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
07/01/2004US20040126326 Delivery of antidepressants through an inhalation route
07/01/2004US20040123401 Colorfastness; mixture containing oxidation base and coupler
07/01/2004DE10260730A1 Neue substituierte stickstoffhaltige Heterobicyclen, deren Herstellung und deren Verwendung als Arzneimittel New substituted nitrogen containing heterobicycles, their preparation and their use as medicaments
07/01/2004DE10259407A1 New bicyclic nitrogen-containing heteroaryl-substituted amides, are inhibitors of Factor Xa and/or related serine proteases, useful as antithrombotic agents, e.g. for treating or preventing deep leg vein thrombosis
07/01/2004CA2510683A1 Carbazole derivatives and their use as npy-5 antagonists